跳至主要内容
临床试验/NCT04234490
NCT04234490已完成不适用

Longitudinal Evaluation of Patient Outcomes and Impact Assessment on Family Members of Home Parenteral Nutrition: New Directions for Research

University of Manchester1 个研究点 分布在 1 个国家目标入组 912 人开始时间: 2020年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
912
试验地点
1
主要终点
Patient reported outcomes

研究概览

简要总结

Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients.

The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN.

This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.

详细描述

Providing a person with food through a vein is known as parenteral nutrition (PN) or artificial tube feeding. This process is used when nutrients from food can't be taken in by the intestine (intestinal failure). Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients.

It is important to assess patients quality of life and their own reported effects of the HPN. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN.

A recent study involving the use of the PNIQ in multiple hospitals in the UK, showed that those on fewer nights of HPN had better quality of life than those on more nights of HPN. Whilst this was useful for looking at quality of life at one time point, it is now important to assess change in quality life over time and any impact on family members quality of life.

This study will recruit HPN patients across the UK and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.

The study is being funded by Shire Pharmaceuticals Ltd.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All people in receipt of HPN including new patients
  • Those 18 years and over.
  • A family member or person involved in the healthcare of the participating patient. (We will ask patients to nominate their closest family member who in their opinion is potentially most effected by the parenteral feeding.)
  • Those 18 years and over.

排除标准

  • Cannot give informed consent
  • Cannot read or write in English.
  • Family members not directly involved with caring for participants

结局指标

主要结局

Patient reported outcomes

时间窗: Baseline, five, 10 and 15 months post entry

Change in Patient reported outcomes (PNIQ score) in people receiving HPN. Score from 0-20, with 0 being high Quality of life and 20 being low quality of life.

次要结局

  • Change in number of hours connected to HPN infusions each night(Baseline, five, 10 and 15 months post entry)
  • Length of time receiving HPN(Baseline, five, 10 and 15 months post entry)
  • Change in number of weekly HPN infusions(Baseline, five, 10 and 15 months post entry)
  • Carer burden(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Debra Jones

Nutrition Research Associate

University of Manchester

研究点 (1)

Loading locations...

相似试验